Intratumor heterogeneity of morphometric and stereologic variables in primary ovarian tumors and their omental metastatic deposits

Analytical and Quantitative Cytology and Histology

Volumn 19, Issue 3, 1997, Pages 185-193

  Brinkhuis, Mariël ^a,b   Scheepstra, Cornelis ^a,b   Buist, Marrije R ^a,b   Van Diest, Paul J ^a,b   Baak, Jan P A ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Pathology ^*

Author keywords

Intratumor heterogeneity; Morphometry; Neoplasm metastasis; Omentum; Ovarian neoplasms; Stereology

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; METASTASIS; MORPHOMETRICS; OMENTUM; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; STEREOLOGY;

FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OMENTUM; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

MYCOBACTERIUM AVIUM-INTRACELLULARE;

EID: 0030924778     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baak JPA, Schipper NW, Wisse-Brekelmans ECM, Ceelen T, Bosman FT, Geuns H van, Wils J: The prognostic value of morphometrical features and cellular DNA content in cisplatin treated late ovarian cancer patients. Br J Cancer 1988;57:503-508
2. Weger AR, Ludescher C, Mikuz G, Kemmler G, Reitsamer R, Hausmaninger H, Lindholm J: The value of prognostic indicators in advanced ovarian cancer. Pathol Res Pract 1989; 185:676-679
3. Rodenburg CJ, Cornelisse CJ, Hermans J, Fleuren GJ: DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: A step forward in predicting the clinical outcome. Gynecol Oncol 1988;29:176-187
4. Haapasalo H, Atkin NB, Collan Y, Pesonen E, Paljärvi L: Tumour ploidy, morphometry, histological and clinical features in ovarian carcinoma: Mutual relations. Analyt Cell Pathol 1991;3:261-271
5. Högberg T, Wang G, Risberg B, Guerrier C, Hittson J, Boeryd B, Kågedal B, Simonsen E: Nuclear morphometry: A strong prognostic factor for survival after secondary surgery in advanced ovarian cancer. Int J Gynecol Cancer 1992;2:198-206
6. Ludescher C, Weger A-R, Lindholm J, Oefner D, Hausmaninger H, Reitsamer R, Mikuz G: Prognostic significance of tumour cell morphometry, histopathology and clinical parameters in advanced carcinoma. Int J Gynecol Pathol 1990; 9:343-351
7. Diest PJ van, Baak JPA, Brugghe J, Burg MEL van de, Oosterom AT van, Neijt JP: Quantitative pathologic features as predictors of long term survival in patients with advanced ovarian cancer treated with cisplatin. Int J Gynecol Cancer 1994;4:174-180
8. Buist MR, Kenemans P, Hollander W den, Vermorken JB, Molthoff CJM, Burger CW, Heimerhorst TJM, Baak JPA, Roos JC: Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab′)2 fragments in ovarian carcinoma patients. Cancer Res 1993; 53:5413-5418
9. Gundersen HJG, Jensen EB: Stereologic estimation of the volume-weighted mean nuclear volume of arbitrary particles observed on random sections. J Microsc 1985; 138:127-142
10. Diest PJ van, Fleege JC, Matze-Cok E, Baak JPA: Intra-patient variation between breast cancer axillary lymph node metastases using quantifiable features. Histopathology 1992;21: 257-262
11. Brinkhuis M, Meijer GA, Beliën JAM, Diest PJ van, Baak JPA: Volume-weighted mean nuclear volume and nuclear area in advanced ovarian cancer: A methodological investigation of sampling methods, sampling size and reproducibility (abstr). Proc of the 8th International Symposium on Diagnostic Quantitative Pathology, Amsterdam, September 14-16, 1994
12. Diest PJ van, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, Galen CM van, Kurver PHJ, Bellot SM, Fijnheer J, Gorp LHM van, Kwee WS, Los J, Peterse JL, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG, Willig AWPM, Ariens AT: Reproducibility of mitoses counting in 2469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project. Hum Pathol 1992; 23:603-607
13. Hart IA, Saini A: Biology of tumour metastasis. Lancet 1992;339:1453-1457
14. Frost P, Levin B: Clinical implications of metastatic process. Lancet 1992;339:1458-1461
15. Nowell PC: The clonal evolution of tumor cell populations. Science 1976;194:23-28
16. Woodruff JD, Julian CG: Multiple malignancy in the upper genital tract. Am J Obstet Gynecol 1969;193:810-822
17. Kallioniemi O: Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988;9: 164-169
18. Zangwill BC, Balsara G, Dunton C, Varello M, Rebane BA, Hernandez E, Atkinson BF: Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy. Cancer 1993;71: 2261-2267
19. Kaern J, Tropé CG, Kristensen GB, Pettersen EO: Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma. Cancer 1994;73:1870-1877
20. Takahashi Y, Takenaka A, Ishiguro T, Noda Y: Intratumoral DNA heterogeneity correlated with lymph node involvement and surgical staging in epithelial ovarian cancer by flow cytometry. Cancer 1994;73:3011-3014